Stents Bioresorbable

This channel includes news and new technology innovations for bioresorbable stents (BRS). These devices are also referred to as bioabsorbable stents, bioresorbable scaffolds and dissolving stents. BRS are designed as an alternative to permanent metallic stent implants, which cause issues in a small number of patients with in-stent restenosis, late-stent thrombosis and require use of long-term antiplatelet therapy. Metallic stents also cause issues with CT and MRI imaging and may prevent future options for coronary bypass graft (CABG) surgery. BRS are supposed to remove avoid these issues by dissolving and disappearing from the vessel after a period of 2-4 years. This, returns the vessel to its natural state and allows for the return of vasodilatation and vasoconstriction.


ABSORB STEMI TROFI II trial, ESC 2015, bioresorbable vascular scaffold, BVS, STEMI patients

Image courtesy of Abbott Vascular

Feature | Stents Bioresorbable | September 04, 2015

September 4, 2015 — A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard...

Absorb, BVS, bioresorbable stent
News | Stents Bioresorbable | September 01, 2015

September 1, 2015 — A bioresorbable drug-eluting coronary stent showed similar efficacy and safety results compared...

News | Cath Lab | August 26, 2015

August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report...

bioabsorbable scaffolds, BAS, global market, 2021, 10MM, 5EU, GlobalData

Absorb BVS image courtesy of Abbott

News | Stents Bioresorbable | August 05, 2015

August 5, 2015 — The global market value for...

Boston Scientific, fully absorbable scaffold, FAST study, resorbable
Feature | Stents Bioresorbable | July 20, 2015

July 20, 2015 - Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting...

Fantom, REVA Medical, FANTOM II trial, ACC

Fantom image courtesy of REVA Medical Inc.

News | June 05, 2015

June 5, 2015 - REVA Medical Inc. announced the initiation of patient enrollment in the FANTOM II clinical trial of...

electronic stents, bioresorbable electronic stent, BES

An illustration of the bioresorbable electronic stent developed in the Korean study. It uses a magnesium stent which doubles as a wireless transmission antenna, flexible microelectronic sensors for blood flow and temperature, and a polylactic acid polymer coating with embedded drug-filled nanospheres that release the drug only when stimulated by heat or light. Image from ACS Nano.

Feature | Stents | May 28, 2015 | Dave Fornell

With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials...

ART, PBS, pure bioresorbable scaffold, CE Mark
Feature | May 26, 2015

May 26, 2015 — Privately-held company Arterial Remodeling Technologies (ART) announced CE Mark clearance for its...

Boston Scientific, Synergy, EVOLVE I, EVOLVE II, EuroPCR 2015, results
News | May 22, 2015

May 22, 2015 — Boston Scientific reported positive, long-term data from the EVOLVE Trial of the Synergy everolimus-...

Amaranth Medical, Fortitude BRS, MEND-II, RENASCENT, EuroPCR 2015

Image courtesy of Amaranth Medical

News | May 21, 2015

May 18, 2015 — Amaranth Medical announced plans to report clinical results from the company's ongoing trial of its...

Abbott, Absorb, dissolving stent, resorbable, CE Mark, Europe
News | May 19, 2015

May 19, 2015 — Abbott announced that it has received CE Mark for the latest advancement of its Absorb stent system,...

Boston Scientific, investors, cardiology, growth, expansion
News | May 11, 2015

May 11, 2015 — Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth...

Biotronik, DREAMS, BIOSOLVE-II trial, bioresorbable stent, magnesium

Image courtesy of Biotronik Inc.

News | February 19, 2015

February 19, 2015 — Biotronik announced the completion of enrollment in the BIOSOLVE-II trial — a...

MiStent SES, Micell Technologies, Europe, bioresorbable stents
News | February 17, 2015

February 17, 2015 — Micell Technologies, Inc. announced the commercial availability of the MiStent...

Fantom, Reva Medical, Rutgers, bioresorbable stents

Image courtesy of Reva Medical Inc.

News | February 12, 2015

February 12, 2015 — A new stent for treating cardiovascular disease that incorporates a polymer invented at Rutgers...

Overlay Init